Cargando…
Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis
BACKGROUND: Inflammatory arthritis (IA), including rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA), leads to increased cardiovascular disease occurrence probably due to atherosclerosis. One of the first stages in atherogenesis is endothelial dysfunction (ED). The...
Autores principales: | Deyab, Gia, Hokstad, Ingrid, Whist, Jon Elling, Smastuen, Milada Cvancarova, Agewall, Stefan, Lyberg, Torstein, Ronda, Nicoletta, Mikkelsen, Knut, Hjeltnes, Gunnbjorg, Hollan, Ivana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646156/ https://www.ncbi.nlm.nih.gov/pubmed/29041979 http://dx.doi.org/10.1186/s13075-017-1439-1 |
Ejemplares similares
-
Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
por: Deyab, Gia, et al.
Publicado: (2017) -
Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study
por: Hokstad, Ingrid, et al.
Publicado: (2019) -
Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies
por: Hokstad, Ingrid, et al.
Publicado: (2022) -
Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis
por: Nguyen, Thao H. P., et al.
Publicado: (2021) -
Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis
por: Nguyen, Thao H. P., et al.
Publicado: (2022)